Biotech · Private company
Concordia Laboratories Inc.
Track this companyFree. Adds Concordia Laboratories Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Chemotherapy regimenPhase 3 · Hilar CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Photodynamic therapy-PhotofrinPhase 3 · Hilar CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Stenting procedurePhase 3 · Hilar CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Fiber opticPhase 1 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- Fiber opticPhase 1 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Porfimer sodiumPhase 1 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- Porfimer SodiumPhase 1 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- No interventionLung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Establishment of a PDT Patient RegistryTERMINATED · started Jan 18, 2019ClinicalTrials.gov NCT03589456 · fetched Nov 12, 2026
- Safety of PDT-Photofrin® Prior to Lung SurgeryPHASE1 · COMPLETED · started Aug 14, 2017ClinicalTrials.gov NCT03344861 · fetched Nov 12, 2026
- Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung CancerPHASE1 · COMPLETED · started Jan 26, 2017ClinicalTrials.gov NCT02916745 · fetched Nov 12, 2026
- Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)PHASE3 · TERMINATED · started Nov 12, 2014ClinicalTrials.gov NCT02082522 · fetched Nov 12, 2026